Artelo Biosciences Inc. (ARTL)

1.05

0.02 (1.45%)

At close: Mar 05, 2025, 3:59 PM

1.02

-2.86%

After-hours: Mar 05, 2025, 04:00 PM EST

Artelo Biosciences Cash Flow Statement

Table Mode

Year	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14
Net Income	-10.08M	-7.44M	-4.65M	-2.17M	-2.34M	-234.89K	-29.69K	-15.24K	-15.27K
Depreciation & Amortization	n/a	n/a	500.00	510.00	282.00	600.00	n/a	n/a	n/a
Stock-Based Compensation	2.46M	1.53M	377.77K	425.11K	290K	3.33K	n/a	n/a	n/a
Other Working Capital	-195K	-239K	-169.26K	40.39K	-57.51K	-1.5K	n/a	n/a	n/a
Other Non-Cash Items	-211K	7K	-29.5K	100K	n/a	600.00	n/a	n/a	-14.73K
Deferred Income Tax	n/a	n/a	n/a	-1.01M	n/a	-600	n/a	n/a	n/a
Change in Working Capital	-172K	-242K	-41.28K	-140.02K	443.19K	14.14K	11.2K	1.74K	14.73K
Operating Cash Flow	-8.01M	-6.14M	-4.35M	-2.79M	-1.61M	-216.82K	-18.49K	-13.5K	-15.27K
Capital Expenditures	n/a	n/a	n/a	-1.5M	-845	n/a	n/a	n/a	n/a
Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-13.22M	-3.44M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	16.18M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	2.96M	-3.44M	n/a	-1.5M	-845	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	-108	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	6.01M	3.15K	1.05K	1.84K	42.67K	5.05K	n/a	n/a
Financial Cash Flow	n/a	14.11M	1.98M	8.38M	1.39M	785.35K	5.05K	15.8K	30K
Net Cash Flow	-5.27M	4.49M	-2.28M	4.09M	-235.35K	569.18K	-13.44K	2.3K	14.73K
Free Cash Flow	-8.01M	-6.14M	-4.35M	-4.29M	-1.61M	-216.82K	-18.49K	-13.5K	-15.27K